Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.
Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis. Oncoimmunology. 2021 02 02; 10(1):1877415.